Antibody and Recombinant Protein CDMO and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Antibody and Recombinant Protein CDMO Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Antibody and Recombinant Protein CDMO Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antibody and Recombinant Protein CDMO Overall Market Size
2.1 Global Antibody and Recombinant Protein CDMO Market Size: 2024 VS 2032
2.2 Global Antibody and Recombinant Protein CDMO Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antibody and Recombinant Protein CDMO Players in Global Market
3.2 Top Global Antibody and Recombinant Protein CDMO Companies Ranked by Revenue
3.3 Global Antibody and Recombinant Protein CDMO Revenue by Companies
3.4 Top 3 and Top 5 Antibody and Recombinant Protein CDMO Companies in Global Market, by Revenue in 2024
3.5 Global Companies Antibody and Recombinant Protein CDMO Product Type
3.6 Tier 1, Tier 2, and Tier 3 Antibody and Recombinant Protein CDMO Players in Global Market
3.6.1 List of Global Tier 1 Antibody and Recombinant Protein CDMO Companies
3.6.2 List of Global Tier 2 and Tier 3 Antibody and Recombinant Protein CDMO Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Antibody and Recombinant Protein CDMO Market Size Markets, 2024 & 2032
4.1.2 Antibody CDMO
4.1.3 Recombinant Protein CDMO
4.2 Segmentation by Type - Global Antibody and Recombinant Protein CDMO Revenue & Forecasts
4.2.1 Segmentation by Type - Global Antibody and Recombinant Protein CDMO Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Antibody and Recombinant Protein CDMO Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Antibody and Recombinant Protein CDMO Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Antibody and Recombinant Protein CDMO Market Size, 2024 & 2032
5.1.2 Pharmaceutical Company
5.1.3 Biotechnology Company
5.1.4 Generic Company
5.2 Segmentation by Application - Global Antibody and Recombinant Protein CDMO Revenue & Forecasts
5.2.1 Segmentation by Application - Global Antibody and Recombinant Protein CDMO Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Antibody and Recombinant Protein CDMO Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Antibody and Recombinant Protein CDMO Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Antibody and Recombinant Protein CDMO Market Size, 2024 & 2032
6.2 By Region - Global Antibody and Recombinant Protein CDMO Revenue & Forecasts
6.2.1 By Region - Global Antibody and Recombinant Protein CDMO Revenue, 2020-2025
6.2.2 By Region - Global Antibody and Recombinant Protein CDMO Revenue, 2026-2032
6.2.3 By Region - Global Antibody and Recombinant Protein CDMO Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Antibody and Recombinant Protein CDMO Revenue, 2020-2032
6.3.2 United States Antibody and Recombinant Protein CDMO Market Size, 2020-2032
6.3.3 Canada Antibody and Recombinant Protein CDMO Market Size, 2020-2032
6.3.4 Mexico Antibody and Recombinant Protein CDMO Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Antibody and Recombinant Protein CDMO Revenue, 2020-2032
6.4.2 Germany Antibody and Recombinant Protein CDMO Market Size, 2020-2032
6.4.3 France Antibody and Recombinant Protein CDMO Market Size, 2020-2032
6.4.4 U.K. Antibody and Recombinant Protein CDMO Market Size, 2020-2032
6.4.5 Italy Antibody and Recombinant Protein CDMO Market Size, 2020-2032
6.4.6 Russia Antibody and Recombinant Protein CDMO Market Size, 2020-2032
6.4.7 Nordic Countries Antibody and Recombinant Protein CDMO Market Size, 2020-2032
6.4.8 Benelux Antibody and Recombinant Protein CDMO Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Antibody and Recombinant Protein CDMO Revenue, 2020-2032
6.5.2 China Antibody and Recombinant Protein CDMO Market Size, 2020-2032
6.5.3 Japan Antibody and Recombinant Protein CDMO Market Size, 2020-2032
6.5.4 South Korea Antibody and Recombinant Protein CDMO Market Size, 2020-2032
6.5.5 Southeast Asia Antibody and Recombinant Protein CDMO Market Size, 2020-2032
6.5.6 India Antibody and Recombinant Protein CDMO Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Antibody and Recombinant Protein CDMO Revenue, 2020-2032
6.6.2 Brazil Antibody and Recombinant Protein CDMO Market Size, 2020-2032
6.6.3 Argentina Antibody and Recombinant Protein CDMO Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Antibody and Recombinant Protein CDMO Revenue, 2020-2032
6.7.2 Turkey Antibody and Recombinant Protein CDMO Market Size, 2020-2032
6.7.3 Israel Antibody and Recombinant Protein CDMO Market Size, 2020-2032
6.7.4 Saudi Arabia Antibody and Recombinant Protein CDMO Market Size, 2020-2032
6.7.5 UAE Antibody and Recombinant Protein CDMO Market Size, 2020-2032
7 Companies Profiles
7.1 Batavia Biosciences
7.1.1 Batavia Biosciences Corporate Summary
7.1.2 Batavia Biosciences Business Overview
7.1.3 Batavia Biosciences Antibody and Recombinant Protein CDMO Major Product Offerings
7.1.4 Batavia Biosciences Antibody and Recombinant Protein CDMO Revenue in Global Market (2020-2025)
7.1.5 Batavia Biosciences Key News & Latest Developments
7.2 Grifols
7.2.1 Grifols Corporate Summary
7.2.2 Grifols Business Overview
7.2.3 Grifols Antibody and Recombinant Protein CDMO Major Product Offerings
7.2.4 Grifols Antibody and Recombinant Protein CDMO Revenue in Global Market (2020-2025)
7.2.5 Grifols Key News & Latest Developments
7.3 Cerbios-Pharma SA
7.3.1 Cerbios-Pharma SA Corporate Summary
7.3.2 Cerbios-Pharma SA Business Overview
7.3.3 Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Major Product Offerings
7.3.4 Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Revenue in Global Market (2020-2025)
7.3.5 Cerbios-Pharma SA Key News & Latest Developments
7.4 HALIX
7.4.1 HALIX Corporate Summary
7.4.2 HALIX Business Overview
7.4.3 HALIX Antibody and Recombinant Protein CDMO Major Product Offerings
7.4.4 HALIX Antibody and Recombinant Protein CDMO Revenue in Global Market (2020-2025)
7.4.5 HALIX Key News & Latest Developments
7.5 Biovian Oy
7.5.1 Biovian Oy Corporate Summary
7.5.2 Biovian Oy Business Overview
7.5.3 Biovian Oy Antibody and Recombinant Protein CDMO Major Product Offerings
7.5.4 Biovian Oy Antibody and Recombinant Protein CDMO Revenue in Global Market (2020-2025)
7.5.5 Biovian Oy Key News & Latest Developments
7.6 Catalent
7.6.1 Catalent Corporate Summary
7.6.2 Catalent Business Overview
7.6.3 Catalent Antibody and Recombinant Protein CDMO Major Product Offerings
7.6.4 Catalent Antibody and Recombinant Protein CDMO Revenue in Global Market (2020-2025)
7.6.5 Catalent Key News & Latest Developments
7.7 Goodwin Biotechnology
7.7.1 Goodwin Biotechnology Corporate Summary
7.7.2 Goodwin Biotechnology Business Overview
7.7.3 Goodwin Biotechnology Antibody and Recombinant Protein CDMO Major Product Offerings
7.7.4 Goodwin Biotechnology Antibody and Recombinant Protein CDMO Revenue in Global Market (2020-2025)
7.7.5 Goodwin Biotechnology Key News & Latest Developments
7.8 Merck
7.8.1 Merck Corporate Summary
7.8.2 Merck Business Overview
7.8.3 Merck Antibody and Recombinant Protein CDMO Major Product Offerings
7.8.4 Merck Antibody and Recombinant Protein CDMO Revenue in Global Market (2020-2025)
7.8.5 Merck Key News & Latest Developments
7.9 Hangzhou Hs-biopharm
7.9.1 Hangzhou Hs-biopharm Corporate Summary
7.9.2 Hangzhou Hs-biopharm Business Overview
7.9.3 Hangzhou Hs-biopharm Antibody and Recombinant Protein CDMO Major Product Offerings
7.9.4 Hangzhou Hs-biopharm Antibody and Recombinant Protein CDMO Revenue in Global Market (2020-2025)
7.9.5 Hangzhou Hs-biopharm Key News & Latest Developments
7.10 Wuxibiologics
7.10.1 Wuxibiologics Corporate Summary
7.10.2 Wuxibiologics Business Overview
7.10.3 Wuxibiologics Antibody and Recombinant Protein CDMO Major Product Offerings
7.10.4 Wuxibiologics Antibody and Recombinant Protein CDMO Revenue in Global Market (2020-2025)
7.10.5 Wuxibiologics Key News & Latest Developments
7.11 Bioinnobio
7.11.1 Bioinnobio Corporate Summary
7.11.2 Bioinnobio Business Overview
7.11.3 Bioinnobio Antibody and Recombinant Protein CDMO Major Product Offerings
7.11.4 Bioinnobio Antibody and Recombinant Protein CDMO Revenue in Global Market (2020-2025)
7.11.5 Bioinnobio Key News & Latest Developments
7.12 Thousand Oaks Biopharmaceuticals
7.12.1 Thousand Oaks Biopharmaceuticals Corporate Summary
7.12.2 Thousand Oaks Biopharmaceuticals Business Overview
7.12.3 Thousand Oaks Biopharmaceuticals Antibody and Recombinant Protein CDMO Major Product Offerings
7.12.4 Thousand Oaks Biopharmaceuticals Antibody and Recombinant Protein CDMO Revenue in Global Market (2020-2025)
7.12.5 Thousand Oaks Biopharmaceuticals Key News & Latest Developments
7.13 Eurogentec
7.13.1 Eurogentec Corporate Summary
7.13.2 Eurogentec Business Overview
7.13.3 Eurogentec Antibody and Recombinant Protein CDMO Major Product Offerings
7.13.4 Eurogentec Antibody and Recombinant Protein CDMO Revenue in Global Market (2020-2025)
7.13.5 Eurogentec Key News & Latest Developments
7.14 HJB
7.14.1 HJB Corporate Summary
7.14.2 HJB Business Overview
7.14.3 HJB Antibody and Recombinant Protein CDMO Major Product Offerings
7.14.4 HJB Antibody and Recombinant Protein CDMO Revenue in Global Market (2020-2025)
7.14.5 HJB Key News & Latest Developments
7.15 Bibo Pharma
7.15.1 Bibo Pharma Corporate Summary
7.15.2 Bibo Pharma Business Overview
7.15.3 Bibo Pharma Antibody and Recombinant Protein CDMO Major Product Offerings
7.15.4 Bibo Pharma Antibody and Recombinant Protein CDMO Revenue in Global Market (2020-2025)
7.15.5 Bibo Pharma Key News & Latest Developments
7.16 MabPlex International
7.16.1 MabPlex International Corporate Summary
7.16.2 MabPlex International Business Overview
7.16.3 MabPlex International Antibody and Recombinant Protein CDMO Major Product Offerings
7.16.4 MabPlex International Antibody and Recombinant Protein CDMO Revenue in Global Market (2020-2025)
7.16.5 MabPlex International Key News & Latest Developments
7.17 Genscriptprobio
7.17.1 Genscriptprobio Corporate Summary
7.17.2 Genscriptprobio Business Overview
7.17.3 Genscriptprobio Antibody and Recombinant Protein CDMO Major Product Offerings
7.17.4 Genscriptprobio Antibody and Recombinant Protein CDMO Revenue in Global Market (2020-2025)
7.17.5 Genscriptprobio Key News & Latest Developments
7.18 Vetter
7.18.1 Vetter Corporate Summary
7.18.2 Vetter Business Overview
7.18.3 Vetter Antibody and Recombinant Protein CDMO Major Product Offerings
7.18.4 Vetter Antibody and Recombinant Protein CDMO Revenue in Global Market (2020-2025)
7.18.5 Vetter Key News & Latest Developments
7.19 Etinpro (Beijing) Co
7.19.1 Etinpro (Beijing) Co Corporate Summary
7.19.2 Etinpro (Beijing) Co Business Overview
7.19.3 Etinpro (Beijing) Co Antibody and Recombinant Protein CDMO Major Product Offerings
7.19.4 Etinpro (Beijing) Co Antibody and Recombinant Protein CDMO Revenue in Global Market (2020-2025)
7.19.5 Etinpro (Beijing) Co Key News & Latest Developments
7.20 Boehringer Ingelheim BioXcellence
7.20.1 Boehringer Ingelheim BioXcellence Corporate Summary
7.20.2 Boehringer Ingelheim BioXcellence Business Overview
7.20.3 Boehringer Ingelheim BioXcellence Antibody and Recombinant Protein CDMO Major Product Offerings
7.20.4 Boehringer Ingelheim BioXcellence Antibody and Recombinant Protein CDMO Revenue in Global Market (2020-2025)
7.20.5 Boehringer Ingelheim BioXcellence Key News & Latest Developments
7.21 Lonza
7.21.1 Lonza Corporate Summary
7.21.2 Lonza Business Overview
7.21.3 Lonza Antibody and Recombinant Protein CDMO Major Product Offerings
7.21.4 Lonza Antibody and Recombinant Protein CDMO Revenue in Global Market (2020-2025)
7.21.5 Lonza Key News & Latest Developments
7.22 3SBio Inc
7.22.1 3SBio Inc Corporate Summary
7.22.2 3SBio Inc Business Overview
7.22.3 3SBio Inc Antibody and Recombinant Protein CDMO Major Product Offerings
7.22.4 3SBio Inc Antibody and Recombinant Protein CDMO Revenue in Global Market (2020-2025)
7.22.5 3SBio Inc Key News & Latest Developments
7.23 Porton
7.23.1 Porton Corporate Summary
7.23.2 Porton Business Overview
7.23.3 Porton Antibody and Recombinant Protein CDMO Major Product Offerings
7.23.4 Porton Antibody and Recombinant Protein CDMO Revenue in Global Market (2020-2025)
7.23.5 Porton Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Antibody and Recombinant Protein CDMO Market Opportunities & Trends in Global Market
Table 2. Antibody and Recombinant Protein CDMO Market Drivers in Global Market
Table 3. Antibody and Recombinant Protein CDMO Market Restraints in Global Market
Table 4. Key Players of Antibody and Recombinant Protein CDMO in Global Market
Table 5. Top Antibody and Recombinant Protein CDMO Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Antibody and Recombinant Protein CDMO Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Antibody and Recombinant Protein CDMO Revenue Share by Companies, 2020-2025
Table 8. Global Companies Antibody and Recombinant Protein CDMO Product Type
Table 9. List of Global Tier 1 Antibody and Recombinant Protein CDMO Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antibody and Recombinant Protein CDMO Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Antibody and Recombinant Protein CDMO Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Antibody and Recombinant Protein CDMO Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2026-2032
Table 30. Batavia Biosciences Corporate Summary
Table 31. Batavia Biosciences Antibody and Recombinant Protein CDMO Product Offerings
Table 32. Batavia Biosciences Antibody and Recombinant Protein CDMO Revenue (US$, Mn) & (2020-2025)
Table 33. Batavia Biosciences Key News & Latest Developments
Table 34. Grifols Corporate Summary
Table 35. Grifols Antibody and Recombinant Protein CDMO Product Offerings
Table 36. Grifols Antibody and Recombinant Protein CDMO Revenue (US$, Mn) & (2020-2025)
Table 37. Grifols Key News & Latest Developments
Table 38. Cerbios-Pharma SA Corporate Summary
Table 39. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Product Offerings
Table 40. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Revenue (US$, Mn) & (2020-2025)
Table 41. Cerbios-Pharma SA Key News & Latest Developments
Table 42. HALIX Corporate Summary
Table 43. HALIX Antibody and Recombinant Protein CDMO Product Offerings
Table 44. HALIX Antibody and Recombinant Protein CDMO Revenue (US$, Mn) & (2020-2025)
Table 45. HALIX Key News & Latest Developments
Table 46. Biovian Oy Corporate Summary
Table 47. Biovian Oy Antibody and Recombinant Protein CDMO Product Offerings
Table 48. Biovian Oy Antibody and Recombinant Protein CDMO Revenue (US$, Mn) & (2020-2025)
Table 49. Biovian Oy Key News & Latest Developments
Table 50. Catalent Corporate Summary
Table 51. Catalent Antibody and Recombinant Protein CDMO Product Offerings
Table 52. Catalent Antibody and Recombinant Protein CDMO Revenue (US$, Mn) & (2020-2025)
Table 53. Catalent Key News & Latest Developments
Table 54. Goodwin Biotechnology Corporate Summary
Table 55. Goodwin Biotechnology Antibody and Recombinant Protein CDMO Product Offerings
Table 56. Goodwin Biotechnology Antibody and Recombinant Protein CDMO Revenue (US$, Mn) & (2020-2025)
Table 57. Goodwin Biotechnology Key News & Latest Developments
Table 58. Merck Corporate Summary
Table 59. Merck Antibody and Recombinant Protein CDMO Product Offerings
Table 60. Merck Antibody and Recombinant Protein CDMO Revenue (US$, Mn) & (2020-2025)
Table 61. Merck Key News & Latest Developments
Table 62. Hangzhou Hs-biopharm Corporate Summary
Table 63. Hangzhou Hs-biopharm Antibody and Recombinant Protein CDMO Product Offerings
Table 64. Hangzhou Hs-biopharm Antibody and Recombinant Protein CDMO Revenue (US$, Mn) & (2020-2025)
Table 65. Hangzhou Hs-biopharm Key News & Latest Developments
Table 66. Wuxibiologics Corporate Summary
Table 67. Wuxibiologics Antibody and Recombinant Protein CDMO Product Offerings
Table 68. Wuxibiologics Antibody and Recombinant Protein CDMO Revenue (US$, Mn) & (2020-2025)
Table 69. Wuxibiologics Key News & Latest Developments
Table 70. Bioinnobio Corporate Summary
Table 71. Bioinnobio Antibody and Recombinant Protein CDMO Product Offerings
Table 72. Bioinnobio Antibody and Recombinant Protein CDMO Revenue (US$, Mn) & (2020-2025)
Table 73. Bioinnobio Key News & Latest Developments
Table 74. Thousand Oaks Biopharmaceuticals Corporate Summary
Table 75. Thousand Oaks Biopharmaceuticals Antibody and Recombinant Protein CDMO Product Offerings
Table 76. Thousand Oaks Biopharmaceuticals Antibody and Recombinant Protein CDMO Revenue (US$, Mn) & (2020-2025)
Table 77. Thousand Oaks Biopharmaceuticals Key News & Latest Developments
Table 78. Eurogentec Corporate Summary
Table 79. Eurogentec Antibody and Recombinant Protein CDMO Product Offerings
Table 80. Eurogentec Antibody and Recombinant Protein CDMO Revenue (US$, Mn) & (2020-2025)
Table 81. Eurogentec Key News & Latest Developments
Table 82. HJB Corporate Summary
Table 83. HJB Antibody and Recombinant Protein CDMO Product Offerings
Table 84. HJB Antibody and Recombinant Protein CDMO Revenue (US$, Mn) & (2020-2025)
Table 85. HJB Key News & Latest Developments
Table 86. Bibo Pharma Corporate Summary
Table 87. Bibo Pharma Antibody and Recombinant Protein CDMO Product Offerings
Table 88. Bibo Pharma Antibody and Recombinant Protein CDMO Revenue (US$, Mn) & (2020-2025)
Table 89. Bibo Pharma Key News & Latest Developments
Table 90. MabPlex International Corporate Summary
Table 91. MabPlex International Antibody and Recombinant Protein CDMO Product Offerings
Table 92. MabPlex International Antibody and Recombinant Protein CDMO Revenue (US$, Mn) & (2020-2025)
Table 93. MabPlex International Key News & Latest Developments
Table 94. Genscriptprobio Corporate Summary
Table 95. Genscriptprobio Antibody and Recombinant Protein CDMO Product Offerings
Table 96. Genscriptprobio Antibody and Recombinant Protein CDMO Revenue (US$, Mn) & (2020-2025)
Table 97. Genscriptprobio Key News & Latest Developments
Table 98. Vetter Corporate Summary
Table 99. Vetter Antibody and Recombinant Protein CDMO Product Offerings
Table 100. Vetter Antibody and Recombinant Protein CDMO Revenue (US$, Mn) & (2020-2025)
Table 101. Vetter Key News & Latest Developments
Table 102. Etinpro (Beijing) Co Corporate Summary
Table 103. Etinpro (Beijing) Co Antibody and Recombinant Protein CDMO Product Offerings
Table 104. Etinpro (Beijing) Co Antibody and Recombinant Protein CDMO Revenue (US$, Mn) & (2020-2025)
Table 105. Etinpro (Beijing) Co Key News & Latest Developments
Table 106. Boehringer Ingelheim BioXcellence Corporate Summary
Table 107. Boehringer Ingelheim BioXcellence Antibody and Recombinant Protein CDMO Product Offerings
Table 108. Boehringer Ingelheim BioXcellence Antibody and Recombinant Protein CDMO Revenue (US$, Mn) & (2020-2025)
Table 109. Boehringer Ingelheim BioXcellence Key News & Latest Developments
Table 110. Lonza Corporate Summary
Table 111. Lonza Antibody and Recombinant Protein CDMO Product Offerings
Table 112. Lonza Antibody and Recombinant Protein CDMO Revenue (US$, Mn) & (2020-2025)
Table 113. Lonza Key News & Latest Developments
Table 114. 3SBio Inc Corporate Summary
Table 115. 3SBio Inc Antibody and Recombinant Protein CDMO Product Offerings
Table 116. 3SBio Inc Antibody and Recombinant Protein CDMO Revenue (US$, Mn) & (2020-2025)
Table 117. 3SBio Inc Key News & Latest Developments
Table 118. Porton Corporate Summary
Table 119. Porton Antibody and Recombinant Protein CDMO Product Offerings
Table 120. Porton Antibody and Recombinant Protein CDMO Revenue (US$, Mn) & (2020-2025)
Table 121. Porton Key News & Latest Developments
List of Figures
Figure 1. Antibody and Recombinant Protein CDMO Product Picture
Figure 2. Antibody and Recombinant Protein CDMO Segment by Type in 2024
Figure 3. Antibody and Recombinant Protein CDMO Segment by Application in 2024
Figure 4. Global Antibody and Recombinant Protein CDMO Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Antibody and Recombinant Protein CDMO Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Antibody and Recombinant Protein CDMO Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Antibody and Recombinant Protein CDMO Revenue in 2024
Figure 9. Segmentation by Type � Global Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Antibody and Recombinant Protein CDMO Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Antibody and Recombinant Protein CDMO Revenue Market Share, 2020-2032
Figure 13. By Region - Global Antibody and Recombinant Protein CDMO Revenue Market Share, 2020-2032
Figure 14. By Country - North America Antibody and Recombinant Protein CDMO Revenue Market Share, 2020-2032
Figure 15. United States Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Antibody and Recombinant Protein CDMO Revenue Market Share, 2020-2032
Figure 19. Germany Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2032
Figure 20. France Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Antibody and Recombinant Protein CDMO Revenue Market Share, 2020-2032
Figure 27. China Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2032
Figure 31. India Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Antibody and Recombinant Protein CDMO Revenue Market Share, 2020-2032
Figure 33. Brazil Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Antibody and Recombinant Protein CDMO Revenue Market Share, 2020-2032
Figure 36. Turkey Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2020-2032
Figure 40. Batavia Biosciences Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Grifols Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. HALIX Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Biovian Oy Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Catalent Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Goodwin Biotechnology Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Merck Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Hangzhou Hs-biopharm Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Wuxibiologics Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. Bioinnobio Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Thousand Oaks Biopharmaceuticals Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. Eurogentec Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. HJB Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 54. Bibo Pharma Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 55. MabPlex International Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 56. Genscriptprobio Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 57. Vetter Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 58. Etinpro (Beijing) Co Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 59. Boehringer Ingelheim BioXcellence Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 60. Lonza Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 61. 3SBio Inc Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 62. Porton Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Industry Market Size
